MUVON Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
7
MUVON Therapeutics General Information
Description
Developer of a biotechnology autologous cell therapy platform designed to facilitate the regeneration of skeletal muscle tissue. The company's platform has the ability to offer the treatment of stress urinary incontinence in women and the treatment of diseases related to skeletal muscle damage or degradation, enabling women to have access to the cure for urinary incontinence and live a healthy life.
Contact Information
Website
www.muvon-therapeutics.comCorporate Office
- C/o ETH Zürich, Weinbergstrasse 35
- WEH G-Stock
- 8092 Zurich
- Switzerland
Corporate Office
- C/o ETH Zürich, Weinbergstrasse 35
- WEH G-Stock
- 8092 Zurich
- Switzerland
MUVON Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 04-May-2023 | Completed | Clinical Trials - Phase 2 | |||
| 6. Accelerator/Incubator | 28-Sep-2022 | Completed | Clinical Trials - Phase 2 | |||
| 5. Early Stage VC (Series A) | 31-May-2021 | Completed | Startup | |||
| 4. Seed Round | Completed | Startup | ||||
| 3. Accelerator/Incubator | 22-Apr-2021 | Completed | Startup | |||
| 2. Accelerator/Incubator | 21-Apr-2021 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
MUVON Therapeutics Signals
MUVON Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Medical Forge | Accelerator/Incubator | |||
| Swiss-Israel Lean Launchpad | Accelerator/Incubator | |||
| Horizon Europe | Not-For-Profit Venture Capital | |||
| Lichtsteiner Foundation | Limited Partner | Minority | ||
| Wyss Zurich | Accelerator/Incubator | Minority |
MUVON Therapeutics FAQs
-
When was MUVON Therapeutics founded?
MUVON Therapeutics was founded in 2020.
-
Where is MUVON Therapeutics headquartered?
MUVON Therapeutics is headquartered in Zurich, Switzerland.
-
What is the size of MUVON Therapeutics?
MUVON Therapeutics has 20 total employees.
-
What industry is MUVON Therapeutics in?
MUVON Therapeutics’s primary industry is Drug Discovery.
-
Is MUVON Therapeutics a private or public company?
MUVON Therapeutics is a Private company.
-
What is MUVON Therapeutics’s current revenue?
The current revenue for MUVON Therapeutics is .
-
How much funding has MUVON Therapeutics raised over time?
MUVON Therapeutics has raised $6.45M.
-
Who are MUVON Therapeutics’s investors?
Medical Forge, Swiss-Israel Lean Launchpad, Horizon Europe, Lichtsteiner Foundation, and Wyss Zurich are 5 of 7 investors who have invested in MUVON Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process